Solid-Phase Extraction and LC–MS Analysis of Benzodiazepines in Urine - - Chromatography Online
Solid-Phase Extraction and LC–MS Analysis of Benzodiazepines in Urine

The Column
Volume 10, Issue 8, pp. 15-20


Standards and Samples: The standards and samples were prepared as follows:

A certified eight component mix in acetonitrile (250 mg/mL per component) was used (Benzodiazepine mix [Cerilliant, B-033]) and contained the following compounds: alprazolam; clonazepam; diazepam; flunitrazepam; lorazepam; nitrazepam; oxazepam; and temazepam.

Working standards for instrument calibration were prepared in 20:80, acetonitrile:H2O solution over a range of 1–500 ng/mL.

Samples were prepared by spiking preserved synthetic urine (Surine, Cerilliant, 720-1) with the benzodiazepine mix at concentrations of 10 ng/mL (low spike) and 150 ng/mL (high spike) of each component.

UHPLC Method: The instruments used to conduct the analysis included a PerkinElmer Flexar FX-10 binary pump, Flexar FX-UHPLC autosampler, and Flexar Peltier column oven. The column used was a 100 mm 2.1 mm, 2.7-m SPP Phenyl-Hexyl (N9308485) (PerkinElmer). Mobile phase A: LC–MS-grade water with 0.1% formic acid and 0.5% acetonitrile. Mobile phase B: LC–MS-grade acetonitrile with 0.1% formic acid. Column temperature: 35 C

Table 1: Gradient programme.
MS Method: The spectrometer used in this analysis was a Flexar SQ300 single-quad mass spectrometer (PerkinElmer) set to the following specifications: Drying gas temperature: 325 C; drying gas (N2) flow rate: 15 L/min; positive ESI mode with capillary exit voltage for all analytes was set at 100 V and dwell time for all ions was 25 ms; single ion monitoring (SIM) was used for all eight compounds.

Calibration Results: The calibration standards used in this experiment were: 1, 5, 10, 50, 100, 250, and 500 ng/mL.

The limit of quantitation (LOQ), or concentration at which quantitative results can be reported with a high degree of confidence, was equal to or below 1 ng/mL

All benzodiazepines analyzed showed excellent curve fits with r2 values of 0.999, demonstrating that the assay was valid over the clinically relevant range.

SPE Method: Spiked Surine samples were prepared at concentrations of 10 ng/mL and 150 ng/mL. These levels were chosen to demonstrate precision and accuracy of the method at both low and high benzodiazepine concentrations. Extractions were conducted on Supra-Poly (PerkinElmer) 30 m and 60 m HLB 96-well plates, 30 mg 2 mL (N9306698 & N9306695, respectively).

The extraction procedure for the benzodiazepines was as follows: The 96-well extraction plates were first conditioned with 1 1 mL methanol followed by 2 1 mL H2O. A 1 mL spiked sample of Surine was loaded onto the 96-well plates. The sample was then washed with 2 1 mL H2O, 1 1 mL 20% acetonitrile and dried for 5–10 min under vacuum. The sample was eluted from the 96-well plate with 1 mL of acetonitrile. The sample was dried under N2 at <40 C and redissolved in 500 L of 20% acetonitrile in H2O.

Table 2: The extraction results for 10 ng/mL spiked Surine samples (low spike) and results for 150 ng/mL spiked Surine samples (high spike) extracted on both solid-phase media A and B.
Extraction Results: Extraction results are provided for both 10 ng/mL spiked Surine and 150 ng/mL spiked surine samples (Table 2). Extractions were conducted on two solid-phase media "A" and "B", differing only in the particle sizes (30-m and 60-m particle diameter, respectively) to assess the two media types for recovery and reproducibility for the benzodiazepine mixture at a low and a high concentration spike.


Even with small detection windows, using SPE with LC–MS offers a highly reliable method to analyze benzodiazepines in urine with a recovery rate that exceeds 90%. It provides clean extracts and a single, simple protocol for a wide range of compounds. SPE also allows for robust and reproducible results even when the sample matrices vary from patient to patient. Finally, using the SPE process to test for benzodiazepines in urine can be automated, which speeds up procedures and helps laboratories to become more efficient and productive.




Jason P. Weisenseel is currently the Chromatography Technical Leader for Aftermarkets with PerkinElmer, Environmental Health, Inc. (Shelton, Connecticut, USA), and a visiting research associate at Vanderbilt University (Nashville, Tennessee, USA). He was a tenured assistant professor of Chemistry at the University of North Alabama (Florence, Alabama, USA) prior to joining PerkinElmer, where he taught chemical instrumental analysis. Weisenseel earned a PhD in chemistry from Vanderbilt University in 2000.




blog comments powered by Disqus
LCGC E-mail Newsletters
Global E-newsletters subscribe here:



Column Watch: Ron Majors, established authority on new column technologies, keeps readers up-to-date with new sample preparation trends in all branches of chromatography and reviews developments. LATEST: When Bad Things Happen to Good Food: Applications of HPLC to Detect Food Adulteration

Perspectives in Modern HPLC: Michael W. Dong is a senior scientist in Small Molecule Drug Discovery at Genentech in South San Francisco, California. He is responsible for new technologies, automation, and supporting late-stage research projects in small molecule analytical chemistry and QC of small molecule pharmaceutical sciences. LATEST: HPLC for Characterization and Quality Control of Therapeutic Monoclonal Antibodies

MS — The Practical Art: Kate Yu brings her expertise in the field of mass spectrometry and hyphenated techniques to the pages of LCGC. In this column she examines the mass spectrometric side of coupled liquid and gas-phase systems. Troubleshooting-style articles provide readers with invaluable advice for getting the most from their mass spectrometers. LATEST: Radical Mass Spectrometry as a New Frontier for Bioanalysis

LC Troubleshooting: LC Troubleshooting sets about making HPLC methods easier to master. By covering the basics of liquid chromatography separations and instrumentation, John Dolan is able to highlight common problems and provide remedies for them. LATEST: How Much Can I Inject? Part I: Injecting in Mobile Phase

More LCGC Columnists>>

LCGC North America Editorial Advisory Board>>

LCGC Europe Editorial Advisory Board>>

LCGC Editorial Team Contacts>>

Source: The Column,
Click here